Description

NovoRapid FlexPen Injection Liquid 100 IU/ml Syringes-Pencils 3 ml №5

Ingredients:

NovoRapid FlexPen contains insulin aspart, glycerol, metacresol, zinc, disodium hydrogen phosphate dihydrate, sodium chloride, and water for injections.

Dosage:

The dosage of NovoRapid FlexPen should be individualized based on the patient’s needs. It is usually injected subcutaneously 5 to 10 minutes before a meal. Consult a healthcare provider for the correct dosage.

Indications:

NovoRapid FlexPen is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above.

Contraindications:

Do not use NovoRapid FlexPen if you are allergic to any of the ingredients, experiencing hypoglycemia, or if the solution is not clear and colorless.

Directions:

NovoRapid FlexPen should be stored in a refrigerator but not in the freezer. Keep it away from direct heat and light. Do not use if frozen or if the insulin has expired.

Scientific Evidence:

Studies have shown that NovoRapid FlexPen is effective in controlling blood sugar levels in patients with diabetes. Research published in the Journal of Diabetes Science and Technology demonstrated the rapid onset of action and shorter duration of NovoRapid compared to regular human insulin.

Additional Information:

NovoRapid FlexPen is a fast-acting insulin analog that mimics the body’s natural insulin response. It helps regulate blood sugar levels after meals, reducing the risk of hyperglycemia. Clinical trials have shown that NovoRapid is well-tolerated and effective in managing diabetes, offering patients flexibility and convenience in insulin administration.

Pharmacologically, NovoRapid FlexPen works by stimulating glucose uptake in muscle and adipose tissue, inhibiting hepatic glucose production, and suppressing lipolysis and proteolysis. This helps to lower blood sugar levels rapidly after injection, making it a valuable tool in diabetes management.

Compared to traditional insulins, NovoRapid FlexPen offers a more predictable and rapid onset of action, allowing for better postprandial glucose control. Its convenient pen device simplifies dosing and administration, improving patient adherence and overall glycemic control.